PLAU and neoplasm: Another property of the TME that has been harnessed in recent years to attempt a more selective engagement of solid tumors is the presence of tumor-selective proteases that are inactive or not expressed in normal tissues, including matriptase, urokinase-type plasminogen activator (uPA), legumain, and MMP2/9 (126, 127).